BioNTech Aktie
WKN DE: A2PSR2 / ISIN: US09075V1026
10.03.2025 12:04:33
|
BioNTech SE Q4 Income Retreats, But Beats Estimates
(RTTNews) - BioNTech SE (BNTX) announced a profit for fourth quarter that decreased from the same period last year but beat the Street estimates.
The company's earnings totaled $259.5 million, or $1.08 per share. This compares with $457.9 million, or $1.88 per share, last year.
Analysts on average had expected the company to earn $0.37 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 19.5% to $1.190 billion from $1.479 billion last year.
BioNTech SE earnings at a glance (GAAP) :
-Earnings: $259.5 Mln. vs. $457.9 Mln. last year. -EPS: $1.08 vs. $1.88 last year. -Revenue: $1.190 Bln vs. $1.479 Bln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioNTech (ADRs)mehr Nachrichten
Analysen zu BioNTech (ADRs)mehr Analysen
20.05.25 | BioNTech Buy | Jefferies & Company Inc. | |
13.05.25 | BioNTech Buy | Deutsche Bank AG | |
07.05.25 | BioNTech Neutral | UBS AG | |
06.05.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.05.25 | BioNTech Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
BioNTech (ADRs) | 86,95 | 0,75% |
|